ACADIA Pharmaceuticals
ACAD
#3513
Rank
โ‚ฌ3.70 B
Marketcap
21,62ย โ‚ฌ
Share price
-0.89%
Change (1 day)
9.24%
Change (1 year)

Revenue for ACADIA Pharmaceuticals (ACAD)

Revenue in 2026 (TTM): โ‚ฌ0.93 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.96 Billion. In 2025 the company made a revenue of โ‚ฌ0.91 Billion a decrease over the revenue in the year 2024 that were of โ‚ฌ0.92 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ACADIA Pharmaceuticals from 2003 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ0.93 B2.53%
2025 โ‚ฌ0.91 B-0.9%
2024 โ‚ฌ0.92 B40.06%
2023 โ‚ฌ0.65 B36.28%
2022 โ‚ฌ0.48 B12.79%
2021 โ‚ฌ0.42 B19.03%
2020 โ‚ฌ0.35 B18.66%
2019 โ‚ฌ0.30 B54.72%
2018 โ‚ฌ0.19 B87.94%
2017 โ‚ฌ0.10 B531.78%
2016 โ‚ฌ16.47 M29433.7%
2015 โ‚ฌ0.05 M-43.92%
2014 โ‚ฌ0.09 M-88%
2013 โ‚ฌ0.82 M-77.65%
2012 โ‚ฌ3.7 M133.07%
2011 โ‚ฌ1.59 M-94.98%
2010 โ‚ฌ31.67 M609.36%
2009 โ‚ฌ4.46 M292.64%
2008 โ‚ฌ1.13 M-78.02%
2007 โ‚ฌ5.17 M-16.06%
2006 โ‚ฌ6.16 M-33.35%
2005 โ‚ฌ9.24 M172.49%
2004 โ‚ฌ3.39 M-45.35%
2003 โ‚ฌ6.21 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ84.66 B 8,698.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ55.62 B 5,680.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ63.47 B 6,496.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ42.59 B 4,326.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
โ‚ฌ0.19 B-80.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
โ‚ฌ77.48 M-91.95%๐Ÿ‡บ๐Ÿ‡ธ USA